SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001724521-24-000144
Filing Date
2024-08-27
Accepted
2024-08-27 16:12:21
Documents
13
Period of Report
2024-08-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant

Document Format Files

Seq Description Document Type Size
1 8-K rcus-20240827.htm   iXBRL 8-K 35538
  Complete submission text file 0001724521-24-000144.txt   160531

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rcus-20240827.xsd EX-101.SCH 1892
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rcus-20240827_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rcus-20240827_pre.xml EX-101.PRE 12502
15 EXTRACTED XBRL INSTANCE DOCUMENT rcus-20240827_htm.xml XML 2714
Mailing Address 3928 POINT EDEN WAY HAYWARD CA 94545
Business Address 3928 POINT EDEN WAY HAYWARD CA 94545 (510) 694-6200
Arcus Biosciences, Inc. (Filer) CIK: 0001724521 (see all company filings)

IRS No.: 473898435 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38419 | Film No.: 241249146
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)